CONDITION
Cholangiohepatitis in Cats
Cholangiohepatitis in cats describes inflammation affecting the bile ducts and surrounding liver tissue. The bile ducts carry digestive fluid from the liver to the intestine, and when they become inflamed, the normal flow and function of bile can be disrupted. This can happen suddenly or develop more gradually over time. Owners often notice a cat becoming quieter, eating less, or losing weight. Some cats develop a yellow tinge to the gums or skin, and vomiting or changes in thirst may also appear. The pattern and severity of signs can vary considerably, and because the liver is involved in many body processes, the picture an owner observes may be subtle or quite pronounced. This page explores the signals that may point towards cholangiohepatitis, what may be happening in the liver and bile ducts to produce those signals, how the condition is investigated, and the range of approaches that exist depending on the underlying pattern and cause.
Why this matters now
Cholangiohepatitis can appear at any age, though certain patterns are more common at particular life stages. The acute neutrophilic form tends to occur in younger to middle-aged cats, often in association with bacterial infection ascending from the intestine. The chronic lymphocytic form is seen more frequently in older cats, and may develop gradually without an obvious trigger. Some cats experience recurrent episodes over months or years.
The trajectory varies considerably depending on the underlying pattern. Some cats experience a sudden onset of signs that develop over days, whilst others show a slow, insidious decline in appetite and body condition over weeks to months. In cases where inflammation becomes established, the liver tissue may undergo changes that affect its structure and function over time. Response to treatment and the degree of ongoing inflammation influence whether signs resolve, stabilise, or continue to progress.
Signals & patterns
Early signals
Reduced interest in food
A cat may begin to eat smaller portions, take longer over meals, or walk away from food that would normally be appealing. This can be subtle at first, appearing as pickiness rather than clear refusal.
Quieter behaviour
The cat may spend more time resting, show less interest in play or interaction, and adopt a hunched or tucked posture when sitting. These changes can be gradual and easy to attribute to other causes.
Occasional vomiting
Vomiting may occur intermittently, sometimes containing food, bile, or froth. The frequency can vary, and in the early stages it may not happen daily.
Weight loss
Loss of body condition may become noticeable over weeks, particularly along the spine and over the hips. In longer-haired cats, this can be harder to detect without handling.
Later signals
Jaundice
A yellow discolouration may appear in the whites of the eyes, the gums, or the skin inside the ears. This develops when bile pigments accumulate in the tissues rather than being excreted normally.
Increased thirst and urination
Some cats begin to drink more water than usual and produce larger volumes of urine. This can reflect changes in the way the kidneys and liver are managing fluid and waste.
Abdominal discomfort
A cat may resent being picked up, react when the abdomen is touched, or adopt a tense posture. The liver may be enlarged or tender, though this is not always outwardly apparent.
Click to read about the biological mechanisms
How this is usually investigated
Investigation of cholangiohepatitis typically begins with a detailed history and physical examination, paying attention to the timeline of signs, any jaundice, abdominal discomfort, and patterns of eating or weight loss. Blood tests help characterise liver enzyme changes and assess whether bile flow is impaired. Imaging and, in many cases, sampling of liver tissue provide information about the structure of the liver, the degree of inflammation, and whether bacteria or other processes are involved.
Blood biochemistry and haematology
Abdominal ultrasound
Fine-needle aspiration or liver biopsy
Bile culture
Assessment of concurrent conditions
Options & trade-offs
Management of cholangiohepatitis is usually tailored to the pattern of inflammation, the presence or absence of bacteria, and how the individual cat is responding over time. Most approaches involve a combination of medications, nutritional support, and monitoring for changes in signs or liver function. What is workable for one household or cat may differ from another, and the balance between ease of administration, tolerability, and response tends to be individual.
Antibiotic therapy
Antibiotics are commonly used when bacterial infection is suspected or confirmed, particularly in acute neutrophilic cholangiohepatitis. Treatment may last several weeks to months, depending on response and whether bile cultures were obtained. Antibiotics are often chosen based on their ability to penetrate bile and liver tissue.
Trade-offs: Long courses of antibiotics can be difficult to administer in cats, and some individuals experience gastrointestinal upset or reduced appetite. In cases where bacteria are not the primary driver, antibiotics may offer limited benefit.
Immunosuppressive medication
Corticosteroids or other immunosuppressive drugs are used in chronic lymphocytic cholangiohepatitis, where the inflammation appears to be immune-mediated rather than infectious. These medications aim to reduce the immune response targeting the bile ducts and liver tissue. Dosing is often gradually reduced over time depending on clinical response.
Trade-offs: Immunosuppressive drugs can increase susceptibility to infection and may cause side effects such as increased thirst, appetite changes, or muscle loss with prolonged use. They are less appropriate in cases where bacterial infection has not been ruled out.
Nutritional support and appetite stimulation
Maintaining calorie intake is important in cats with cholangiohepatitis, as the liver's metabolic functions are already compromised and prolonged inappetence can worsen liver damage. Appetite stimulants, anti-nausea medication, or feeding tubes may be used if a cat is not eating voluntarily. Diets that are easily digestible and support liver function are sometimes offered.
Trade-offs: Feeding tubes require placement under sedation or anaesthesia and ongoing home care, which may not be practical for all owners. Appetite stimulants may have variable effectiveness and can cause behavioural changes or restlessness in some cats.
Ursodeoxycholic acid
Ursodeoxycholic acid is a bile acid that may help protect liver cells, improve bile flow, and reduce inflammation. It is often used alongside other treatments in both acute and chronic forms of cholangiohepatitis.
Trade-offs: The evidence for its effectiveness in cats is less robust than in some other species, and it is usually considered a supportive measure rather than a primary treatment. It is generally well tolerated, though some cats may experience diarrhoea.
Monitoring and adjustment over time
Regular follow-up with blood tests, weight checks, and observation of appetite and behaviour allows treatment to be adjusted as the condition evolves. Some cats require ongoing medication, whilst others may be weaned off treatment if inflammation resolves. The frequency and type of monitoring depend on the severity of disease and the individual's response.
Trade-offs: Repeated veterinary visits and blood tests add to the practical and financial commitment, and may be stressful for some cats. The balance between close monitoring and allowing a settled routine at home varies between households.
Common misconceptions
"Cholangiohepatitis is always caused by infection and always requires antibiotics."
Whilst bacterial infection is a common driver of acute cholangiohepatitis, many cats have a chronic form where inflammation appears to be immune-mediated and bacteria are not identified. In these cases, antibiotics are less likely to be the mainstay of treatment, and immunosuppressive medications may play a larger role. Distinguishing the pattern of inflammation, ideally through tissue sampling, helps guide which approach is most relevant.
"Jaundice always means the liver is failing."
Jaundice indicates that bilirubin is accumulating in the bloodstream, which can happen when bile flow is obstructed or when the liver is inflamed and unable to process bilirubin efficiently. It does not necessarily mean that the liver has lost its ability to function altogether. Many cats with cholangiohepatitis and jaundice respond to treatment, and liver function can improve as inflammation subsides.
"Once a cat has recovered from cholangiohepatitis, it will not happen again."
Some cats experience a single episode that resolves with treatment, whilst others have a chronic or recurrent pattern, particularly in the lymphocytic form. The underlying tendency towards inflammation or the anatomical relationship between the bile ducts and intestine may predispose certain individuals to repeated episodes. Long-term monitoring and, in some cases, ongoing low-dose medication may be part of managing a cat with recurrent disease.
Related conditions
Pancreatitis in Cats
Pancreatitis in cats can occur alongside cholangiohepatitis, and the two conditions may share common inflammatory pathways or arise together due to the close anatomical relationship between the pancreatic duct and the bile duct. Some cats present with both conditions simultaneously, a pattern sometimes referred to as triaditis when inflammatory bowel disease is also present.
Inflammatory Bowel Disease in Cats
Inflammatory bowel disease in cats can occur concurrently with cholangiohepatitis, particularly in cases where inflammation affects multiple digestive organs. The shared inflammatory environment and anatomical proximity may mean that inflammation in one organ influences or triggers changes in another.
Cholelithiasis
Cholelithiasis may occur in cats with cholangiohepatitis, as inflammation and altered bile flow can create conditions that favour stone formation within the bile ducts or gallbladder. Conversely, stones can obstruct bile flow and contribute to or worsen inflammation in the bile duct system.
Acute Pancreatitis
Acute pancreatitis can occur together with cholangiohepatitis in cats, and the two conditions may influence one another through shared inflammatory mediators or because of the close anatomical connection between the pancreatic and biliary systems. Distinguishing between the two, or recognising both when present, often requires careful clinical assessment.
Obesity in Cats
Obesity in cats can alter metabolic and inflammatory pathways in ways that may influence susceptibility to liver and biliary disease. Excess body weight is also associated with hepatic lipidosis, another liver condition that can sometimes complicate or coexist with cholangiohepatitis.
Cholangiohepatitis often coexists with inflammation in the pancreas or intestine, and understanding how these systems interact can provide a fuller picture of what may be influencing a cat's signs. The broader context of metabolic health, including how the liver supports nutrition, immunity, and waste processing, may be relevant when thinking about recovery and long-term wellbeing. Patterns of appetite, weight, and energy over time can be useful observations to note, particularly if signs change or recur.
Last reviewed: 31 July 2026 · Dr Alastair Greenway MRCVS